Future directions for drug transporter modelling.

Area of Science:

• Computational chemistry
• Drug discovery
• Pharmacology

Background:

• Since the late 1980s, computational methods have increasingly been used to study drug-transporter interactions, beginning with P-glycoprotein (P-gp).
• Identifying molecules interacting with transporters like P-gp is crucial for drug discovery but typically requires time-consuming in vitro and in vivo experiments.

Purpose of the Study:

• To highlight the utility of computational quantitative structure-activity relationship (QSAR) and pharmacophore models in predicting drug-transporter interactions.
• To demonstrate how these computational approaches can expedite the identification of novel drug substrates and inhibitors for transporters.

Main Methods:

• Application of quantitative structure-activity relationship (QSAR) and pharmacophore modeling.
• Rapid screening of molecular databases to identify potential transporter substrates or inhibitors.
• Verification of computational predictions through in vitro studies.

Main Results:

• Computational models enable rapid screening of large molecule databases, identifying potential binders for transporters.
• The use of these models has led to the discovery of new substrates and inhibitors for various transporters.
• Accurate predictions of transporter binding by computational and pharmacophore models can anticipate drug-drug interactions.

Conclusions:

• Computational QSAR and pharmacophore models offer an efficient alternative to traditional methods for assessing drug-transporter interactions.
• These models can accelerate drug discovery by prioritizing molecules for experimental validation and predicting potential drug-drug interactions.
• Future integration of these computational approaches into pharmacokinetic-pharmacodynamic models may enhance predictions of in vivo drug effects.